<DOC>
	<DOCNO>NCT00003824</DOCNO>
	<brief_summary>RATIONALE : Chemoprevention therapy use certain drug try prevent development recurrence cancer . It yet know whether ciprofloxacin effective cephalexin prevent cancer recurrence patient undergo surgery treat bladder cancer . PURPOSE : Randomized phase III trial compare effectiveness ciprofloxacin cephalexin prevent recurrence cancer patient undergo surgery bladder cancer .</brief_summary>
	<brief_title>S9809 , Ciprofloxacin Compared With Cephalexin Treating Patients With Bladder Cancer</brief_title>
	<detailed_description>OBJECTIVES : I . Determine whether ciprofloxacin improves recurrence-free survival patient superficial transitional cell carcinoma bladder treat transurethral tumor resection . OUTLINE : This randomize , multicenter study . Patients stratify accord disease status ( first occurrence v recurrent disease ) . Patients randomize receive either oral ciprofloxacin oral cephalexin 2 time day 3 day start night resection . Patients allergic penicillin cephalosporin receive oral co-trimoxazole 2 time day 3 day . All patient undergo complete resection bladder tumor . Patients follow every 3 month first 2 year , every 6 month next 2 year , end fifth year . PROJECTED ACCRUAL : A total 900 patient accrue study 3 year .</detailed_description>
	<mesh_term>Urinary Bladder Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Transitional Cell</mesh_term>
	<mesh_term>Ciprofloxacin</mesh_term>
	<mesh_term>Cephalexin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Stage Ta ( grade ) transitional cell carcinoma bladder basis cystoscopy Recurrent disease great T1 Must high risk upper tract ( ureter renal pelvic ) transitional cell cancer PATIENT CHARACTERISTICS : Age : 18 Performance status : SWOG 02 Life expectancy : Not specify Hematopoietic : Not specify Hepatic : Not specify Renal : Not specify Other : Not pregnant nursing Fertile patient must use effective contraception No prior malignancy past 5 year except adequately treat basal cell squamous cell skin cancer , carcinoma situ cervix , adequately treated stage I II cancer complete remission No allergy fluoroquinolones If allergic penicillin cephalosporin , must able take cotrimoxazole PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : At least 28 day since prior intravesical therapy recover Endocrine therapy : Not specify Radiotherapy : At least 28 day since prior radiotherapy recover Surgery : Not specify Other : At least 3 month prior cystoscopy since prior fluoroquinolones No concurrent fluoroquinolones No concurrent hemodialysis peritoneal dialysis No concurrent probenecid theophylline No concurrent antacid contain aluminum , magnesium calcium , product contain iron zinc , caffeine , cyclosporine , warfarin</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>stage 0 bladder cancer</keyword>
	<keyword>recurrent bladder cancer</keyword>
	<keyword>transitional cell carcinoma bladder</keyword>
</DOC>